Skip to content
Simpler Grants

No. RFA-AI-27-005 · National Institutes of Health

Open

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

grants.gov listing
Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Award range
Not specified
Expected awards
Not specified
Application deadline
Nov 10, 2026
Posted
Sep 1, 2026
Last verified
5 days ago

At a glance

No plain-language summary yet for this grant — the official description below is the best source.

What it funds

  • Health
  • Research & Discovery
  • Training, Fellowship & Career Development
  • Patients & People with Health Conditions
  • Researchers & Scholars
  • Biomedical & Disease Research
Official description from grants.gov

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR). AMR is a major health challenge that limits treatment options and allows resistant infections to persist. Individuals with chronic conditions like diabetes and cancer are particularly vulnerable, resulting in increased illness and death as well as higher healthcare costs in the United States. The program aims to design, implement, and manage clinical research addressing key clinical questions in AMR. Research will focus on bacterial and fungal infections associated with AMR. Areas of emphasis include clinical testing of new antibiotics and other treatments such as bacteriophage therapy, methods optimizing the use of existing antibiotics, evaluating novel diagnostic tests including using diagnostics to refine treatment strategies, and mentoring the next generation of AMR clinical researchers. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Who can apply

  • City or township governments
  • For-profit organizations other than small businesses
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Others
  • Private institutions of higher education
  • Public and State controlled institutions of higher education
  • Small businesses
  • Special district governments
Geographic restriction None found in the announcement — likely nationwide

Program history

USASpending.gov

Assistance listing 93.855 · Allergy and Infectious Diseases Research

Real awards this federal program has made — the whole assistance listing (93.855), not just this notice.

Fiscal year Awards Median award Middle half
FY 2026 (so far) 1,817 $295,722 $146,402 – $737,210
FY 2025 1,596 — —
FY 2024 1,720 — —
FY 2023 1,711 — —
FY 2022 1,576 — —
FY 2021 1,857 — —

Dollar figures are based on the 1,000 most recent awards we store, not all 10,277 — award counts are complete.

Who wins it Higher education (7,336), Nonprofit (1,735), Business (694) of 10,277 awards — categories can overlap.
Top states CA (122) · MA (85) · NY (78) · PA (69) · TX (47)
Largest recent awards
  1. SCRIPPS RESEARCH INSTITUTE $3,679,976 · FY 2026
  2. REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE $3,499,366 · FY 2026
  3. UNIVERSITY OF WASHINGTON $3,414,775 · FY 2026
  4. UNIVERSITY OF FLORIDA $3,389,992 · FY 2026
  5. ALBERT EINSTEIN COLLEGE OF MEDICINE $3,204,071 · FY 2026

Source: USASpending.gov · refreshed Aug 23, 2026

Change history

Since we first indexed it
  1. Sep 2, 2026 Status: forecasted → open
  2. Sep 2, 2026 Deadline set: Nov 10, 2026
  3. Sep 1, 2026 Title updated